ETHICS and Medical Devices IP: Inequitable Conduct and New PTO Ethical Rules
Brinks Gilson & Lione
Bradford J. “Jim” Badke
Ropes & Gray LLP
- USPTO spotlight: What are OED’s expectations of attorneys in this space?
- Understanding when to raise the inequitable conduct defense under the continually evolving Therasense standard
- Rule 36 affi rmations of inequitable conduct cases
- Update on recent relevant inequitable conduct cases
- Complying with the USPTO duty of disclosure: what to submit and how much?
- Analysis of the PTO’s 2013 ethical Rules of Professional Conduct
- Overview of key provisions including confl icts, sanctions and experts affecting life sciences practitioners
- How do these work with the ABA model rules and state bar rules?
- Avoiding ethical quagmires in the IPR/PGR space for life sciences companies
- What conflicts of interest rules apply with parallel litigation: USPTO or District Court?
- Duty of candor and good faith owed by petitioner challenging the patent
- Avoiding putting forth information inconsistent with a position
- Applying traditional conflicts analysis and principals when agreeing to work for a client: Are ABA comments to the model rules instructional?